Bone morphogenetic protein 2: A potential new player in the pathogenesis of diabetic retinopathy

Experimental Eye Research

Volumn 125, Issue , 2014, Pages

  Hussein, Khaled A ^a,b,c   Choksi, Karishma ^a,b   Akeel, Sara ^a   Ahmad, Saif ^b,d   Megyerdi, Sylvia ^a   El Sherbiny, Mohamed ^a,b,e   Nawaz, Mohamed ^f   Abu El Asrar, Ahmed ^f   Al Shabrawey, Mohamed ^a,b,e,g  

^a Department of Oral Biology Anatomy College of Dental Medicine Georgia Reagents University (GRU)   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c NATIONAL RESEARCH CENTRE   (Egypt)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^e MANSOURA UNIVERSITY   (Egypt)

^f KING SAUD UNIVERSITY   (Saudi Arabia)

^g NONE   (United States)

Author keywords

Blood retinal barrier; BMP 2; Diabetic retinopathy; Inflammation; Leukocyte adhesion; M ller cells; Retinal endothelial cells; VEGF

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CLINICAL EXAMINATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETIC RETINOPATHY; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE ADHERENCE; MOUSE; MUELLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRANSCELLULAR ELECTRICAL RESISTANCE; UPREGULATION; VITREOUS BODY;

BLOOD-RETINAL BARRIER; BMP 2; DIABETIC RETINOPATHY; INFLAMMATION; LEUKOCYTE ADHESION; MÜLLER CELLS; RETINAL ENDOTHELIAL CELLS; VEGF;

ANALYSIS OF VARIANCE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL ADHESION; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; EPENDYMOGLIAL CELLS; HUMANS; MICE; RATS; RETINA; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 84902578564     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2014.05.012     Document Type: Article

References (54)

1. Aiello L.P., Avery R.L., Arrigg P.G., Keyt B.A., Jampel H.D., Shah S.T., Pasquale L.R., Thieme H., Iwamoto M.A., Park J.E., Nguyen H.V., Aiello L.M., Ferrara N., King G.L. Vascular endothelial growth-factor in ocular fluid of patients with diabetic-retinopathy and other retinal disorders. N.Engl. J. Med. 1994, 331:1480-1487.
2. Akeel S., El-awady A., Hussein K., El-Refaey M., Elsalanty M., Sharawy M., Al-Shabrawey M. Recombinant bone morphogenetic protein-2 induces up-regulation of vascular endothelial growth factor and interleukin 6 in human pre-osteoblasts: role of reactive oxygen species. Arch. Oral Biol. 2012, 57:445-452.
3. Al-Shabrawey M., Mussell R., Kahook K., Tawfik A., Eladl M., Sarthy V., Nussbaum J., El-Marakby A., Park S.Y., Gurel Z., Sheibani N., Maddipati K.R. Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy implications in retinal neovascularization. Diabetes 2011, 60:614-624.
4. Al-Shabrawey M., Rojas M., Sanders T., Behzadian A., El-Remessy A., Bartoli M., Parpia A.K., Liou G., Caldwell R.B. Role of NADPH oxidase in retinal vascular inflammation. Investig. Ophthalmol. Vis. Sci. 2008, 49:3239-3244.
5. Bandello F., Lattanzio R., Zucchiatti I., Del Turco C. Pathophysiology and treatment of diabetic retinopathy. Acta Diabetol. 2013, 50:1-20.
6. Bouletreau P.J., Warren S.M., Spector J.A., Peled Z.M., Gerrets R.P., Greenwald J.A., Longaker M.T. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast. Reconstr. Surg. 2002, 109:2384-2397.
7. Cilensek I., Hercegovac A., Starcevic J.N., Vukojevic K., Babic M.S., Zivin A.M. Polymorphisms of interleukin-4,-10 and 12B genes and diabetic retinopathy. Central Eur. J. Biol. 2011, 6:558-564.
8. Csiszar A., Ahmad M., Smith K.E., Labinskyy N., Gao O., Kaley G., Edwards J.G., Wolin M.S., Ungvari Z. Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype. Am. J. Pathol. 2006, 168:629-638.
9. Csiszar A., Lehoux S., Ungvari Z. Hemodynamic forces, vascular oxidative stress, and regulation of BMP-2/4 expression. Antioxid. Redox Signal. 2009, 11:1683-1697.
10. Csiszar A., Smith K.E., Koller A., Kaley G., Edwards J.G., Ungvari Z. Regulation of bone morphogenetic protein-2 expression in endothelial cells - role of nuclear factor-kappa B activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation 2005, 111:2364-2372.
11. Demircan N., Safran B.G., Soylu M., Ozcan A.A., Sizmaz S. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye (Lond., Engl.) 2006, 20:1366-1369.
12. Derwall M., Malhotra R., Lai C.S., Beppu Y., Aikawa E., Seehra J.S., Zapol W.M., Bloch K.D., Yu P.B. Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2012, 32. 613-U168.
13. Du Y., Xiao Q., Yip H.K. Regulation of retinal progenitor cell differentiation by bone morphogenetic protein 4 is mediated by the Smad/Id Cascade. Investig. Ophthalmol. Vis. Sci. 2010, 51:3764-3773.
14. Ducy P., Karsenty G. The family of bone morphogenetic proteins. Kidney Int. 2000, 57:2207-2214.
15. Dudley A.T., Robertson E.J. Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev. Dyn. 1997, 208:349-362.
16. Goto H., Nishikawa T., Sonoda K., Kondo T., Kukidome D., Fujisawa K., Yamashiro T., Motoshima H., Matsumura T., Tsuruzoe K., Araki E. Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice. Biochem. Biophys. Res. Commun. 2008, 366:814-820.
17. Guo J., Wu G. The signaling and functions of heterodimeric bone morphogenetic proteins. Cytokine Growth Factor Rev. 2012, 23:61-67.
18. Gustavsson C., Agardh C.-D., Agardh E. Profile of intraocular tumour necrosis factor- and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy. Acta Ophthalmol. 2013, 91:445-452.
19. Heng L.Z., Comyn O., Peto T., Tadros C., Ng E., Sivaprasad S., Hykin P.G. Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet. Med. 2013, 30:640-650.
20. Hussein K.A., Zakhary I.E., Elawady A.R., Emam H.A., Sharawy M., Baban B., Akeel S., Al-Shabrawey M., Elsalanty M.E. Difference in soft tissue response between immediate and delayed delivery suggests a new mechanism for recombinant human bone morphogenetic protein 2 action in large segmental bone defects. Tissue Eng. Part A 2012, 18:665-675.
21. Juel H.B., Faber C., Udsen M.S., Folkersen L., Nissen M.H. Chemokine expression in retinal pigment epithelial ARPE-19 cells in response to coculture with activated T cells. Investig. Ophthalmol. Vis. Sci. 2012, 53:8472-8480.
22. Kelley R., Ren R., Pi X., Wu Y., Moreno I., Willis M., Moser M., Ross M., Podkowa M., Attisano L., Patterson C. Aconcentration-dependent endocytic trap and sink mechanism converts Bmper from an activator to an inhibitor of Bmp signaling. J.Cell Biol. 2009, 184:597-609.
23. Kohno H., Chen Y., Kevany B.M., Pearlman E., Miyagi M., Maeda T., Palczewski K., Maeda A. Photoreceptor proteins initiate microglial activation via toll-like receptor 4 in retinal degeneration mediated by all-trans-retinal. J.Biol. Chem. 2013, 288:15326-15341.
24. Kojima H., Otani A., Oishi A., Makiyama Y., Nakagawa S., Yoshimura N. Granulocyte colony-stimulating factor attenuates oxidative stress-induced apoptosis in vascular endothelial cells and exhibits functional and morphologic protective effect in oxygen-induced retinopathy. Blood 2011, 117:1091-1100.
25. Langenfeld E.M., Langenfeld J. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol. Cancer Res. 2004, 2:141-149.
26. Liberman M., Johnson R.C., Handy D.E., Loscalzo J., Leopold J.A. Bone morphogenetic protein-2 activates NADPH oxidase to increase endoplasmic reticulum stress and human coronary artery smooth muscle cell calcification. Biochem. Biophys. Res. Commun. 2011, 413:436-441.
27. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. Cell Biol. 2012, 13:27-38.
28. Mathura J.R., Jafari N., Chang J.T., Hackett S.F., Wahlin K.J., Della N.G., Okamoto N., Zack D.J., Campochiaro P.A. Bone morphogenetic proteins-2 and-4: negative growth regulators in adult retinal pigmented epithelium. Investig. Ophthalmol. Vis. Sci. 2000, 41:592-600.
29. Matsubara H., Hogan D.E., Morgan E.F., Mortlock D.P., Einhorn T.A., Gerstenfeld L.C. Vascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesis. Bone 2012, 51:168-180.
30. Monaghan-Benson E., Wittchen E.S. Invitro analyses of endothelial cell permeability. Methods Mol. Biol. (Clift., N.J.) 2011, 763:281-290.
31. Moreno-Miralles I., Ren R., Moser M., Hartnett M.E., Patterson C. Bone morphogenetic protein endothelial cell precursor-derived regulator regulates retinal angiogenesis invivo in a mouse model of oxygen-induced retinopathy. Arterioscler. Thromb. Vasc. Biol. 2011, 31. 2216-U2166.
32. Moser M., Binder O., Wu Y.X., Aitsebaomo J., Ren R.Q., Bode C., Bautch V.L., Conlon F.L., Patterson C. BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation. Mol. Cell. Biol. 2003, 23:5664-5679.
33. Oishi A., Otani A., Sasahara M., Kojima H., Nakamura H., Yodoi Y., Yoshimura N. Granulocyte colony-stimulating factor protects retinal photoreceptor cells against light-induced damage. Investig. Ophthalmol. Vis. Sci. 2008, 49:5629-5635.
34. Othman A., Ahmad S., Megyerdi S., Mussell R., Choksi K., Maddipati K.R., Elmarakby A., Rizk N., Al-Shabrawey M. 12/15-lipoxygenase-derived lipid metabolites induce retinal endothelial cell barrier dysfunction: contribution of NADPH oxidase. Plos One 2013, 8.
35. Paine S.K., Basu A., Mondal L.K., Sen A., Choudhuri S., Chowdhury I.H., Saha A., Bhadhuri G., Mukherjee A., Bhattacharya B. Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes. Mol. Vis. 2012, 18:2749-2757.
36. Paine S.K., Sen A., Choudhuri S., Mondal L.K., Chowdhury I.H., Basu A., Mukherjee A., Bhattacharya B. Association of tumor necrosis factor alpha, interleukin 6, and interleukin 10 promoter polymorphism with proliferative diabetic retinopathy in type 2 diabetic subjects. Retina J. Retin. Vitr. Dis. 2012, 32:1197-1203.
37. Pi X., Lockyer P., Dyer L.A., Schisler J.C., Russell B., Carey S., Sweet D.T., Chen Z., Tzima E., Willis M.S., Homeister J.W., Moser M., Patterson C. Bmper inhibits endothelial expression of inflammatory adhesion molecules and protects against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2214-2222.
38. Rangasamy S., Srinivasan R., Maestas J., McGuire P.G., Das A. Apotential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. Investig. Ophthalmol. Vis. Sci. 2011, 52:3784-3791.
39. Reddi A.H. BMPs: from bone morphogenetic proteins to body morphogenetic proteins. Cytokine Growth Factor Rev. 2005, 16:249-250.
40. Reichenbach A., Bringmann A. New functions of Müller cells. Glia 2013, 61:651-678.
41. Rojas M., Zhang W., Lee D.L., Romero M.J., Nguyen D.T., Al-Shabrawey M., Tsai N.-T., Liou G.I., Brands M.W., Caldwell R.W., Caldwell R.B. Role of IL-6 in angiotensin II-induced retinal vascular inflammation. Investig. Ophthalmol. Vis. Sci. 2010, 51:1709-1718.
42. Shao J.S., Al Aly Z., Lai C.F., Cai S., Huang E., Behrmann A., Towler D.A. Vascular Bmp-Msx2-Wnt signaling and oxidative stress in arterial calcification. Skeletal Biology and Medicine, Pt B: Disease Mechanisms and Therapeutic Challenges 2007, 40-50. M. Zaidi (Ed.).
43. Smith L.E.H., Kopchick J.J., Chen W., Knapp J., Kinose F., Daley D., Foley E., Smith R.G., Schaeffer J.M. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 1997, 276:1706-1709.
44. Stitt A.W., Lois N., Medina R.J., Adamson P., Curtis T.M. Advances in our understanding of diabetic retinopathy. Clin. Sci. 2013, 125:1-17.
45. Tsuji K., Bandyopadhyay A., Harfe B.D., Cox K., Kakar S., Gerstenfeld L., Einhorn T., Tabin C.J., Rosen V. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat. Genet. 2006, 38:1424-1429.
46. Urist M.R. Bone: formation by autoinduction. Sci. (New York, N.Y.) 1965, 150:893-899.
47. Wagner D.O., Sieber C., Bhushan R., Boergermann J.H., Graf D., Knaus P. BMPs: from bone to body morphogenetic proteins. Sci. Signal. 2010, 3.
48. Wang J., Xu X., Elliott M.H., Zhu M., Le Y.-Z. Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes 2010, 59:2297-2305.
49. Wilkinson-Berka J.L., Rana I., Armani R., Agrotis A. Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy. Clin. Sci. 2013, 124:597-615.
50. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., Hewick R.M., Wang E.A. Novel regulators of bone-formation - molecular clones and activities. Science 1988, 242:1528-1534.
51. Zhang M., Zhou S.-h, Zhao S., Li X.-p., Liu L.-P., Shen X.-Q. Pioglitazone can downregulate bone morphogenetic protein-2 expression induced by high glucose in human umbilical vein endothelial cells. Pharmacology 2008, 81:312-316.
52. Zhang W., Liu H., Al-Shabrawey M., Caldwell R.W., Caldwell R.B. Inflammation and diabetic retinal microvascular complications. J.Cardiovasc. Dis. Res. 2011, 2:96-103.
53. Zhang X., Bao S., Hambly B.D., Gillies M.C. Vascular endothelial growth factor-A: a multifunctional molecular player in diabetic retinopathy. Int. J. Biochem. Cell Biol. 2009, 41:2368-2371.
54. Zhang X., Saaddine J.B., Chou C.-F., Cotch M.F., Cheng Y.J., Geiss L.S., Gregg E.W., Albright A.L., Klein B.E.K., Klein R. Prevalence of diabetic retinopathy in the United States, 2005-2008. Jama J. Am. Med. Assoc. 2010, 304:649-656.